Rhotekin anticorps (N-Term)
Aperçu rapide pour Rhotekin anticorps (N-Term) (ABIN631197)
Antigène
Voir toutes Rhotekin (RTKN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Rhotekin antibody was raised against the N terminal of RTKN
-
Purification
- Affinity purified
-
Immunogène
- Rhotekin antibody was raised using the N terminal of RTKN corresponding to a region with amino acids DSGPPAERSPCRGRVCISDLRIPLMWKDTEYFKNKGDLHRWAVFLLLQLG
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
Rhotekin Blocking Peptide, (ABIN937549), is also available for use as a blocking control in assays to test for specificity of this Rhotekin antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RTKN antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Rhotekin (RTKN)
-
Autre désignation
- Rhotekin
-
Sujet
- RTKN mediates Rho signaling to activate NF-kappa-B and may confer increased resistance to apoptosis to cells in gastric tumorigenesis. RTKN may play a novel role in the organization of septin structures.
-
Poids moléculaire
- 63 kDa (MW of target protein)
Antigène
-